SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Komarek Luke
(Last) (First) (Middle)
2400 XENIUM LANE NORTH
(Street)
PLYMOUTH MN 55441
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CHRISTOPHER & BANKS CORP [ CBKC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/01/2019 F(1) 1,203 D $0.0823 74,396(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $10.8 04/19/2011(3) 04/19/2020 Common Stock 21,200 21,200 D
Employee Stock Option (Right to Buy) $6.28 04/18/2012(4) 04/18/2021 Common Stock 26,236 26,236 D
Employee Stock Option (Right to Buy) $1.91 03/29/2013(5) 03/29/2022 Common Stock 35,749 35,749 D
Employee Stock Option (Right to Buy) $6.25 03/15/2014(6) 03/15/2023 Common Stock 9,039 9,039 D
Employee Stock Option (Right to Buy) $2.12 09/01/2017(7) 09/01/2026 Common Stock 86,019 86,019 D
Employee Stock Option (Right to Buy) $1.28 03/16/2018(8) 03/16/2027 Common Stock 75,000 75,000 D
Employee Stock Option (Right to Buy) $0.36 03/14/2020(9) 03/14/2029 Common Stock 75,000 75,000 D
Explanation of Responses:
1. Represents a transaction involving a disposition to the Company of equity securities upon the vesting of restricted stock whereby the reporting person used a portion of the shares that vested to satisfy the resulting tax withholding obligations.
2. This number includes restricted stock awards.
3. On April 19, 2010, the reporting person was granted an option to purchase 21,200 shares of Common Stock. The option vests in three annual installments of 7,066 shares on April 19, 2011, 7,067 shares on April 19, 2012 and 7,067 shares on April 19, 2013.
4. On April 18, 2011, the reporting person was granted an option to purchase 26,236 shares of Common Stock. The option vests in three annual installments of 8,746 shares on April 18, 2012, 8,745 shares on April 18, 2013 and 8,745 shares on April 18, 2014.
5. On March 29, 2012, the reporting person was granted an option to purchase 35,749 shares of Common Stock. The option vests in three annual installments of 11,917 shares on March 29, 2013, 11,916 shares on March 29, 2014 and 11,916 shares on March 29, 2015.
6. On March 15, 2013, the reporting person was granted an option to purchase 9,039 shares of the Company's Common Stock. The option vests in three annual installments of 3,013 shares on each of March 15, 2014, March 15, 2015 and March 15, 2016.
7. On September 1, 2016, the reporting person was granted an option to purchase 86,019 shares of the Company's Common Stock. The option vests in three annual installments of 28,673 shares on each of September 1, 2017, September 1, 2018 and September 1, 2019.
8. On March 16, 2017, the reporting person was granted an option to purchase 75,000 shares of the Company's Common Stock. The option vests in three annual installments of 25,000 shares on each of March 16, 2018, March 16, 2019 and March 16, 2020.
9. On March 14, 2019 the reporting person was granted an option to purchase 75,000 shares of Common Stock. The option vests in 3 annual installments of 25,000 shares on March 14,2020; March 14, 2021; and March 14, 2022.
Remarks:
/s/ Luke Komarek, Attorney-in-Fact 09/05/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.